Chemed Corp
NYSE:CHE

Watchlist Manager
Chemed Corp Logo
Chemed Corp
NYSE:CHE
Watchlist
Price: 570.96 USD 1.36% Market Closed
Market Cap: 8.6B USD
Have any thoughts about
Chemed Corp?
Write Note

Gross Margin
Chemed Corp

35.7%
Current
36%
Average
47.2%
Industry

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
35.7%
=
Gross Profit
847.8m
/
Revenue
2.4B

Gross Margin Across Competitors

Country US
Market Cap 8.6B USD
Gross Margin
36%
Country US
Market Cap 91.8B USD
Gross Margin
11%
Country US
Market Cap 87.7B EUR
Gross Margin
11%
Country US
Market Cap 73B USD
Gross Margin
14%
Country DE
Market Cap 24.9B EUR
Gross Margin
25%
Country US
Market Cap 20.1B USD
Gross Margin
28%
Country DE
Market Cap 18.8B EUR
Gross Margin
24%
Country US
Market Cap 18.3B USD
Gross Margin
33%
Country US
Market Cap 13.7B USD
Gross Margin
33%
Country DE
Market Cap 12.4B EUR
Gross Margin
25%
Country AU
Market Cap 13.4B AUD
Gross Margin
84%
No Stocks Found

Chemed Corp
Glance View

Market Cap
8.6B USD
Industry
Health Care

Chemed Corp. is a distinguished player in the healthcare sector, known primarily for its two main subsidiaries: VITAS Healthcare and Chemed Home Health. VITAS is the nation’s leading provider of hospice and palliative care services, which cater to patients with life-limiting illnesses. This segment underscores Chemed’s dedication to enhancing the quality of life for patients and their families, focusing on compassionate care and support during critical times. Operating in a market increasingly underpinned by an aging population and a growing preference for home-based healthcare solutions, Chemed stands to benefit from favorable demographic trends. In addition, its Chemed Home Health division positions the company well within the rapidly expanding home healthcare market, facilitating personalized care in a familiar environment, which has shown significant promise in improving patient outcomes. For investors, Chemed Corp. offers a compelling investment narrative characterized by steady growth, financial stability, and a robust operational model. The company has demonstrated strong revenue generation and consistently high margins, reflective of its effective management and operational efficiencies. With a solid balance sheet and commitment to shareholder returns, Chemed has a track record of delivering value through dividends and strategic reinvestments. Moreover, as healthcare policies increasingly favor in-home care solutions and as demographics shift towards an older population, Chemed is poised to capture considerable market opportunities. Its proven ability to adapt to changing healthcare needs not only underlines its resilience but also highlights its potential for sustained financial performance and long-term growth.

CHE Intrinsic Value
503.31 USD
Overvaluation 12%
Intrinsic Value
Price

See Also

Discover More
What is Gross Margin?

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
35.7%
=
Gross Profit
847.8m
/
Revenue
2.4B
What is the Gross Margin of Chemed Corp?

Based on Chemed Corp's most recent financial statements, the company has Gross Margin of 35.7%.